UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 272

Sortiert nach

Maternal Ezh1/2 deficiency impairs the function of mitochondria in mouse oocytes and early embryos

Journal of cellular physiology, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis

Journal of pineal research, 2016-09, Vol.61 (2), p.208-217

2016

Link zum Volltext

Verfügbarkeit prüfen

circEZH2E2/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression

Cancer science, 2023-04, Vol.114 (4), p.1378-1395

2023

Link zum Volltext

Verfügbarkeit prüfen

Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy

NMR in biomedicine, 2023-05, Vol.36 (5), p.e4694-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Natural products modulating epigenetic mechanisms by affecting histone methylation/demethylation: Targeting cancer cells

British journal of pharmacology, 2023-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous Delivery of Doxorubicin and EZH2‐Targeting siRNA by Vortex Magnetic Nanorods Synergistically Improved Anti‐Tumor Efficacy in Triple‐Negative Breast Cancer (Small 43/2023)

Small (Weinheim an der Bergstrasse, Germany), 2023-10, Vol.19 (43), p.n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

EZH2 regulates H2B phosphorylation and elevates colon cancer cell autophagy

Journal of cellular physiology, 2020-02, Vol.235 (2), p.1494-1503

2020

Link zum Volltext

Verfügbarkeit prüfen

Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer

International journal of cancer, 2019-07, Vol.145 (2), p.415-426

2019

Link zum Volltext

Verfügbarkeit prüfen

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

The EMBO journal, 2003-10, Vol.22 (20), p.5323-5335

2003

Link zum Volltext

Verfügbarkeit prüfen

LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression

Journal of cellular biochemistry, 2018-06, Vol.119 (6), p.4496-4505

2018

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell lines

BioFactors (Oxford), 2019-09, Vol.45 (5), p.818-829

2019

Link zum Volltext

Verfügbarkeit prüfen

The functions of EZH2 in immune cells: Principles for novel immunotherapies

Journal of leukocyte biology, 2021-07, Vol.110 (1), p.77-87

2021

Link zum Volltext

Verfügbarkeit prüfen

LncRNA CARMN facilitates odontogenic differentiation of dental pulp cells by impairing EZH2

Oral diseases, 2023-05

2023

Link zum Volltext

Verfügbarkeit prüfen

Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global trimethylation of H3K27

Journal of cellular and molecular medicine, 2020-03, Vol.24 (6), p.3336-3345

2020

Link zum Volltext

Verfügbarkeit prüfen

LncRNA SNHG8 accelerates proliferation and inhibits apoptosis in HPV‐induced cervical cancer through recruiting EZH2 to epigenetically silence RECK expression

Journal of cellular biochemistry, 2020-10, Vol.121 (10), p.4120-4129

2020

Link zum Volltext

Verfügbarkeit prüfen

Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program

Pediatric blood & cancer, 2017-03, Vol.64 (3), p.np-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma

Journal of internal medicine, 2023-09, Vol.294 (3), p.295-313

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas

Brain pathology (Zurich, Switzerland), 2013-09, Vol.23 (5), p.558-564

2013

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer

The Prostate, 2023-11, Vol.83 (15), p.1458-1469

2023

Link zum Volltext

Verfügbarkeit prüfen

miR‐124‐3p attenuates neuropathic pain induced by chronic sciatic nerve injury in rats via targeting EZH2

Journal of cellular biochemistry, 2019-04, Vol.120 (4), p.5747-5755

2019

Link zum Volltext

Verfügbarkeit prüfen

An NF‐κB‐responsive long noncoding RNA, PINT, regulates TNF‐α gene transcription by scaffolding p65 and EZH2

The FASEB journal, 2021-09, Vol.35 (9), p.e21667-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype

International journal of cancer, 2019-12, Vol.145 (11), p.2974-2985

2019

Link zum Volltext

Verfügbarkeit prüfen

Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57KIP2 and involving in p‐p38 MAPK and NF‐κB pathways

Journal of cellular biochemistry, 2019-03, Vol.120 (3), p.3978-3988

2019

Link zum Volltext

Verfügbarkeit prüfen

Long noncoding RNA LINC00630 promotes radio‐resistance by regulating BEX1 gene methylation in colorectal cancer cells

IUBMB life, 2020-07, Vol.72 (7), p.1404-1414

2020

Link zum Volltext

Verfügbarkeit prüfen

EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors

Andrology (Oxford), 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 272

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(270)

Publikationsform

Artikel
(272)

Sprache

Englisch
(272)
Japanisch
(65)

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Life Sciences & Biomedicine
(246)
Ezh2
(241)
Humans
(177)
Cell Biology
(88)
Female
(82)
Animals
(81)
Male
(76)
Tumors
(74)
Oncology
(73)
Cell Line, Tumor
(72)
Gene Expression
(69)
Enhancer Of Zeste Homolog 2 Protein - Metabolism
(66)
Enhancer Of Zeste Homolog 2 Protein
(64)
Biochemistry & Molecular Biology
(63)
Enhancer Of Zeste Homolog 2 Protein - Genetics
(58)
Proteins
(58)
Cell Proliferation
(52)
Mice
(52)
Epigenetics
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Maternal Ezh1/2 deficiency impairs the function of mitochondria in mouse oocytes and early embryos

Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis

circEZH2E2/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression

Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy

Natural products modulating epigenetic mechanisms by affecting histone methylation/demethylation: Targeting cancer cells

Simultaneous Delivery of Doxorubicin and EZH2‐Targeting siRNA by Vortex Magnetic Nanorods Synergistically Improved Anti‐Tumor Efficacy in Triple‐Negative Breast Cancer (Small 43/2023)

EZH2 regulates H2B phosphorylation and elevates colon cancer cell autophagy

Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression

Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell lines

The functions of EZH2 in immune cells: Principles for novel immunotherapies

LncRNA CARMN facilitates odontogenic differentiation of dental pulp cells by impairing EZH2

Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global trimethylation of H3K27

LncRNA SNHG8 accelerates proliferation and inhibits apoptosis in HPV‐induced cervical cancer through recruiting EZH2 to epigenetically silence RECK expression

Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma

Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas

Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer

miR‐124‐3p attenuates neuropathic pain induced by chronic sciatic nerve injury in rats via targeting EZH2

An NF‐κB‐responsive long noncoding RNA, PINT, regulates TNF‐α gene transcription by scaffolding p65 and EZH2

BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype

Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57KIP2 and involving in p‐p38 MAPK and NF‐κB pathways

Long noncoding RNA LINC00630 promotes radio‐resistance by regulating BEX1 gene methylation in colorectal cancer cells

EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors

Aktive Filter

Suchergebnisse filtern